Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P32189
UPID:
GLPK_HUMAN
Alternative names:
ATP:glycerol 3-phosphotransferase
Alternative UPACC:
P32189; A6NJP5; B2R833; Q6IQ27; Q8IVR5; Q9UMP0; Q9UMP1
Background:
Glycerol kinase, encoded by the gene with accession number P32189, plays a pivotal role as a key enzyme in the regulation of glycerol uptake and metabolism. Known alternatively as ATP:glycerol 3-phosphotransferase, this protein is essential for the proper handling of glycerol within the cell, facilitating its conversion into a form that can be readily utilized in metabolic pathways.
Therapeutic significance:
Glycerol kinase deficiency (GKD) manifests in various forms, from severe developmental delay and adrenal insufficiency in its infantile form to asymptomatic adult cases. Understanding the role of Glycerol kinase could open doors to potential therapeutic strategies, offering hope for targeted interventions in metabolic disorders like GKD.